FOCLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
EDAP TMS SA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 14, 2026
$4.07−0.02 (-0.49%)
Close on Oct 19, 2026
EDAP TMS SA revenue by segment
By business segment
| Revenue | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DISTRIB Division | €31.29M | €29.92M | €27.91M | €23.13M | €17.34M | €16.58M | €13.66M | – | – | – | 48.8% | +4.6% |
| High Intensity Focused Ultrasound (HIFU) | €23.84M | €20.60M | €15.63M | €9.92M | €11.44M | €14.14M | €11.04M | €9.51M | €13.82M | €8.48M | 37.2% | +15.7% |
| Lithotripsy (ESWL) | €8.98M | €9.91M | €11.57M | €11.02M | – | – | – | – | – | – | 14.0% | -9.3% |
| Urology Devices and Services (ESWL) | – | – | €11.57M | €11.02M | €12.88M | €14.19M | €14.48M | €26.23M | €21.79M | €23.78M | – | – |
| FDA [Member] | – | – | – | – | – | – | – | – | – | €0 | – | – |
| EDAP TMS (Corporate) [Member] | – | – | – | – | – | – | – | – | – | €0 | – | – |
| High Intensity Focused Ultrasound (HIFU) [Member] | – | – | – | – | – | – | – | – | €13.82M | €8.48M | – | – |
| Urology Devices and Services (UDS) [Member] | – | – | – | – | – | – | – | – | €21.79M | €23.78M | – | – |
| FDA [Member] | – | – | €55.11M | €44.07M | €41.66M | €44.91M | €39.18M | €35.75M | €35.61M | – | – | – |
| Operating income | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lithotripsy (ESWL) | €1.21M | -€232.00K | €922.00K | €893.00K | – | – | – | – | – | – | -621.6% |
| DISTRIB Division | -€571.00K | -€248.00K | €1.97M | €2.42M | €1.10M | €1.40M | €451.00K | – | – | – | +130.2% |
| High Intensity Focused Ultrasound (HIFU) | -€17.46M | -€14.78M | -€4.89M | -€3.03M | -€445.00K | €459.00K | -€2.33M | -€2.70M | €964.00K | €523.00K | +18.1% |
| Urology Devices and Services (ESWL) | – | – | €922.00K | €893.00K | €1.08M | €1.64M | €1.80M | €2.04M | €742.00K | €1.64M | – |
| FDA [Member] | – | – | – | – | – | – | – | – | – | -€311.00K | – |
| EDAP TMS (Corporate) [Member] | – | – | – | – | – | – | – | – | – | -€1.36M | – |
| High Intensity Focused Ultrasound (HIFU) [Member] | – | – | – | – | – | – | – | – | €964.00K | €523.00K | – |
| Urology Devices and Services (UDS) [Member] | – | – | – | – | – | – | – | – | €742.00K | €1.64M | – |
| Corporate Segment [Member] | – | – | – | – | – | – | – | – | – | -€1.36M | – |
| FDA [Member] | – | – | -€4.26M | -€1.61M | €269.00K | €2.20M | -€1.32M | -€2.03M | €392.00K | -€311.00K | – |
| EDAP Technomed Co Ltd. [Member] | – | – | – | – | – | -€1.30M | -€1.25M | -€1.36M | -€1.32M | -€1.36M | – |
By product or service
| Revenue | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goods | €44.04M | €42.33M | €38.46M | €29.04M | €27.52M | €30.11M | €25.07M | – | – | – | 68.7% | +4.0% |
| Spare parts and services | €12.47M | €11.91M | €11.03M | €10.05M | €9.38M | €9.00M | €9.01M | €8.01M | €6.63M | €5.90M | 19.4% | +4.6% |
| RPPs & leases | €7.61M | €6.18M | €5.62M | €4.97M | €4.75M | €5.75M | €5.09M | €5.10M | €4.91M | €4.41M | 11.9% | +23.2% |
| Product | – | €60.42M | €55.11M | €44.06M | €41.65M | €44.86M | €39.16M | €22.58M | €24.05M | €21.91M | – | – |
| External other revenues | – | – | – | €6.00K | – | €52.00K | €19.00K | €60.00K | €32.00K | €35.00K | – | – |
| Product and Services, Excluding Other [Member] | – | – | – | – | – | €44.86M | €39.16M | €35.69M | €35.58M | €32.22M | – | – |
| Licenses and Others [Member] | – | – | – | – | – | €52.00K | €19.00K | €60.00K | €32.00K | €35.00K | – | – |
| Licenses and others | – | – | – | €6.00K | €12.00K | €52.00K | €19.00K | – | – | – | – | – |
| Other revenues | – | – | – | €6.00K | €12.00K | €52.00K | €19.00K | – | – | – | – | – |
By region
| Revenue | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | €19.04M | €17.84M | €17.94M | €16.01M | €15.87M | €17.94M | €14.12M | €13.46M | €10.43M | – | 29.7% | +6.7% |
| United States | €18.22M | €16.72M | €15.04M | €5.52M | €5.61M | €5.19M | €2.05M | €1.75M | €3.42M | – | 28.4% | +9.0% |
| Other geographical areas | €15.61M | €13.87M | €11.50M | €10.28M | €10.15M | €10.38M | €11.42M | €9.90M | €12.13M | – | 24.4% | +12.6% |
| France | €11.24M | €12.00M | €10.64M | €12.25M | €10.02M | €11.35M | €11.58M | €10.57M | €9.61M | – | 17.5% | -6.3% |
From the segment and revenue-disaggregation notes of Edap Tms's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.